Zestagen SA

we develop monoclonal antibodies against cancer metastasis: the industry's 1st antibody to extracellular HSP 90, a validated oncology target

  • Stage Product In Development
  • Industry Biotechnology
  • Location Chemin des Croisettes, Epalinges, VD, Switzerland
  • Currency CHF
  • Founded October 2011
  • Employees 1
  • Website zestagen.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free